Planned maintenance

We must perform activities that will impact the ability to place orders on our website. Starting Friday, May 21, at 5:00 p.m. Eastern to Sunday, May 23, at 5:00 p.m. Eastern, you will not be able to order products on our website. You will still be able to browse atcc.org and access your account. We apologize for any inconvenience this work may cause.
X

Mycobacterium boenickei Schinsky et al. (ATCC® 49935)

Strain Designations: MF 657 [DSM 44677, W5998]  /  Type Strain: yes  /  Biosafety Level: 2

Permits and Restrictions

View Permits

Deposited As Mycobacterium fortuitum da Costa Cruz
Strain Designations MF 657 [DSM 44677, W5998]
Isolation
Tissue, human, Birmingham Alabama, United States
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Storage Conditions Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section
Preceptrol® no
Type Strain yes RefSchinsky MF, et al. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates.. Int. J. Syst. Evol. Microbiol. 54: 1653-1667, 2004. PubMed: 15388725
Comments
Third biovariant complex
Medium ATCC® Medium 18: Trypticase Soy Agar/Broth
Growth Conditions
Temperature: 35°C
Atmosphere: Aerobic
Name of Depositor RJ Wallace
Chain of Custody
ATCC <-- RJ Wallace <-- Roche Biomedical Labs
Isolation
Tissue, human, Birmingham Alabama, United States
References

Wallace RJ J, et al. Clinical disease, drug susceptibility, and biochemical patterns of the unnamed third biovariant complex of Mycobacterium fortuitum. J. Infect. Dis. 163: 598-603, 1991. PubMed: 1995732

Schinsky MF, et al. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates.. Int. J. Syst. Evol. Microbiol. 54: 1653-1667, 2004. PubMed: 15388725

leg wound, Birmingham, AL

Schinsky MF, et al. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates.. Int. J. Syst. Evol. Microbiol. 54: 1653-1667, 2004. PubMed: 15388725

Cross References

Nucleotide (GenBank) : AY012573 Mycobacterium bonickei strain W5998 16S ribosomal RNA gene, partial sequence.

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation